Curemark Competitors and Similar CompaniesClear all
Curemark's competitors and similar companies include PaxMedica and Incendia Therapeutics.
 Curemark Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders. |  PaxMedica PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS). |  Incendia Therapeutics Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment. | |
Founding Date | Founding Date 2006 | Founding Date 2018 | Founding Date 2019 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Rye, US HQ Rye Brook, US | Locations Tarrytown, US HQ | Locations Boston, US HQ |
Employees | Employees 23 | Employees 2100% increase | Employees 41 |
Funding | |||
Latest funding round | Latest funding round $ 5.4m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 65m (over 4 years ago) |
Total funding raised | Total funding raised $ 55.7m | Total funding raised N/A | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
PaxMedica
HQ
Tarrytown, US
Employees
2
PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS).
View companyIncendia Therapeutics
HQ
Boston, US
Employees
41
Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment.
View company